{
  "Pages 1-2": {
    "num_tested_probands": 1,
    "num_positive_het_probands": 0,
    "positive_phenotypes": [
      "extensively prolonged neuromuscular block"
    ],
    "num_compound_or_double_hets": 1,
    "explanation": {
      "num_tested_probands": "The report discusses the testing and observations of 'a 30-yr-old healthy man', indicating a single proband was tested.",
      "num_positive_het_probands": "The report identifies the proband as compound heterozygous for silent mutations, not heterozygous for a pathogenic variant.",
      "positive_phenotypes": "The patient's phenotype was described as 'extensively prolonged neuromuscular block'.",
      "num_compound_or_double_hets": "The report explicitly states the patient was 'compound heterozygous for silent mutations'."
    },
    "quote_snippets": {
      "num_tested_probands": [
        "The neuromuscular block following administration of mivacurium; at a dose of 0.14 mg/kg, was monitored in a 30-yr-old healthy man"
      ],
      "num_positive_het_probands": [],
      "positive_phenotypes": [
        "Patients who are hOmozygous for the atypical mutation, compound heterozygous for atypical and silent mu- tations, or homozygous for silent mutations (SS) respond to mivacurium with extensively prolonged neuromuscular block",
        "The response t0 mivacurium was an extensively prolonged duration of action."
      ],
      "num_compound_or_double_hets": [
        "The patient was compound heterozygous for silent mutations in the butyrylcholinesterase gene:"
      ]
    },
    "cleaned_quotes": {
      "num_tested_probands": [
        "The neuromuscular block following administration of mivacurium; at a dose of 0.14 mg/kg, was monitored in a 30-yr-old healthy man"
      ],
      "num_positive_het_probands": [],
      "positive_phenotypes": [
        "Patients who are homozygous for the atypical mutation, compound heterozygous for atypical and silent mu- tations, or homozygous for silent mutations (SS) respond to mivacurium with extensively prolonged neuromuscular block",
        "The response to mivacurium was an extensively prolonged duration of action."
      ],
      "num_compound_or_double_hets": [
        "The patient was compound heterozygous for silent mutations in the butyrylcholinesterase gene:"
      ]
    },
    "gene_symbol": [
      "BCHE",
      "NES",
      "PC",
      "SI",
      "STH",
      "TAT"
    ],
    "genomic_hgvs": []
  },
  "Pages 3-4": {
    "num_tested_probands": 5,
    "num_positive_het_probands": 3,
    "positive_phenotypes": [
      "Prolonged duration of action of mivacurium",
      "No or very little active BChE"
    ],
    "num_compound_or_double_hets": 2,
    "explanation": {
      "num_tested_probands": "The patient, his parents, and two brothers were tested for BChE activity, phenotype, and genotype.",
      "num_positive_het_probands": "The father, mother, and one brother were heterozygous for a silent mutation.",
      "positive_phenotypes": "The phenotypes noted include prolonged duration of action of mivacurium and very little/no active BChE.",
      "num_compound_or_double_hets": "The patient and one brother were compound heterozygous for two silent mutations."
    },
    "quote_snippets": {
      "num_tested_probands": [
        "the parents and two brothers had blood samples drawn to determine BChE activity, phenotype, and genotype."
      ],
      "num_positive_het_probands": [
        "the father; the mother; and the other brother are heterozygous for a silent mutation."
      ],
      "positive_phenotypes": [
        "The extremely prolonged duration of action of mivacurium in our patient; who was compound het-",
        "erozygous for two silent mutations, correlates well with the findings described in other reports.",
        "The patient's BChE activity was zero, indicating that he was homozygous for Silent mutations.",
        "Patients with phenotypes SS, AS, or AA all have no or very little active BChE. A prolonged duration of action of mivacurium is therefore to be expected in these pa-",
        "tients."
      ],
      "num_compound_or_double_hets": [
        "Thus, the patient is compound heterozygous for two silent mutations. Accordingly, the parents are both heterozygous for one silent mutation.",
        "One brother has the same genotype as the patient;"
      ]
    },
    "cleaned_quotes": {
      "num_tested_probands": [
        "the parents and two brothers had blood samples drawn to determine BChE activity, phenotype, and genotype."
      ],
      "num_positive_het_probands": [
        "the father, the mother, and the other brother are heterozygous for a silent mutation."
      ],
      "positive_phenotypes": [
        "The extremely prolonged duration of action of mivacurium in our patient; who was compound het-",
        "erozygous for two silent mutations, correlates well with the findings described in other reports.",
        "The patient's BChE activity was zero, indicating that he was homozygous for Silent mutations.",
        "Patients with phenotypes SS, AS, or AA all have no or very little active BChE. A prolonged duration of action of mivacurium is therefore to be expected in these pa-",
        "tients."
      ],
      "num_compound_or_double_hets": [
        "Thus, the patient is compound heterozygous for two silent mutations. Accordingly, the parents are both heterozygous for one silent mutation.",
        "One brother has the same genotype as the patient;"
      ]
    },
    "gene_symbol": [
      "AGA",
      "AGT",
      "BCHE",
      "CAT",
      "GAA",
      "GC",
      "GCA",
      "PC",
      "SI",
      "TAT",
      "TG"
    ],
    "genomic_hgvs": []
  },
  "Pages 5-6": {
    "num_tested_probands": 3,
    "num_positive_het_probands": 2,
    "positive_phenotypes": [
      "decreased BChE activity",
      "prolonged neuromuscular blockade"
    ],
    "num_compound_or_double_hets": 3,
    "explanation": {
      "num_tested_probands": "The text refers to the patient and the three sons, which suggests a testing group of at least three probands.",
      "num_positive_het_probands": "The pedigree shows the patient and two sons with compound heterozygous mutations, indicating at least two are positive heterozygous.",
      "positive_phenotypes": "The report discusses prolonged drug action and decreased enzyme activity as primary phenotypes.",
      "num_compound_or_double_hets": "The compound heterozygous nature is identified in the patient and two sons."
    },
    "quote_snippets": {
      "num_tested_probands": [
        "This mutation, GlylISASp, is present in the mother and the three sons (striped area)",
        "Double peaks (C and T nucleotides; arrow) indicating heterozygous mutation"
      ],
      "num_positive_het_probands": [
        "The pharmacodynamics of mivacurium in patients ho mOzygOus for the atypical mutation and compound het erozygous for a silent and the atypical mutation have been reported"
      ],
      "positive_phenotypes": [
        "The homozygous silent phenotype of BChE is charac terized by complete absence of BChE activity",
        "respond t0 mivacurium by extensively prolonged duration of its action"
      ],
      "num_compound_or_double_hets": [
        "Biochemical data supported the conclusion that the patient was com- pound heterozygous for two silent mutations.",
        "the known S7-variant 18 and an undescribed mutation; which introduced a stop codon at amino acid residue 172"
      ]
    },
    "cleaned_quotes": {
      "num_tested_probands": [
        "This mutation, GlylISASp, is present in the mother and the three sons (striped area)",
        "Double peaks (C and T nucleotides; arrow) indicating heterozygous mutation"
      ],
      "num_positive_het_probands": [
        "The pharmacodynamics of mivacurium in patients ho mOzygOus for the atypical mutation and compound het erozygous for a silent and the atypical mutation have been reported"
      ],
      "positive_phenotypes": [
        "The homozygous silent phenotype of BChE is characterized by complete absence of BChE activity",
        "respond to mivacurium by extensively prolonged duration of its action"
      ],
      "num_compound_or_double_hets": [
        "Biochemical data supported the conclusion that the patient was compound heterozygous for two silent mutations.",
        "the known S7-variant 18 and an undescribed mutation, which introduced a stop codon at amino acid residue 172"
      ]
    },
    "gene_symbol": [
      "AR",
      "BCHE",
      "CIT",
      "CRP",
      "GC",
      "NES",
      "PC",
      "SI",
      "STH",
      "TAT"
    ],
    "genomic_hgvs": []
  },
  "Pages 7-8": {
    "num_tested_probands": 0,
    "num_positive_het_probands": 0,
    "positive_phenotypes": [],
    "num_compound_or_double_hets": 0,
    "explanation": {
      "num_tested_probands": "The text does not specify the number of probands tested.",
      "num_positive_het_probands": "The text does not specify any positive heterozygous probands.",
      "positive_phenotypes": "The text does not describe any specific positive phenotypes.",
      "num_compound_or_double_hets": "The text does not indicate any compound or double heterozygotes."
    },
    "quote_snippets": {
      "num_tested_probands": [],
      "num_positive_het_probands": [],
      "positive_phenotypes": [],
      "num_compound_or_double_hets": []
    },
    "cleaned_quotes": {
      "num_tested_probands": [],
      "num_positive_het_probands": [],
      "positive_phenotypes": [],
      "num_compound_or_double_hets": []
    },
    "gene_symbol": [
      "BCHE",
      "CP",
      "NES",
      "SI",
      "STH"
    ],
    "genomic_hgvs": []
  }
}